Merck & Co. Inc. (MRK)

$ 111.38
   
  • Change Today:
    $-0.92
  • 52 Week High: $123.18
  • 52 Week Low: $73.47
  • Currency: US Dollars
  • Shares Issued: 2,474.63m
  • Volume: 5,725,143
  • Market Cap: $275,624m
  • RiskGrade: 92

Latest ShareCast News

Merck beats Q1 forecasts on strong Keytruda demand

By Benjamin Chiou

Date: Thursday 30 Apr 2026

(Sharecast News) - Merck & Co beat market forecasts with its first-quarter results on Thursday and raised its full-year guidance on the back of strong growth for Keytruda, its flagship humanised monoclonal antibody (PD-1 inhibitor) used to treat 18 types of cancer.

Merck News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 111.38
Change Today $ -0.92
% Change -0.82 %
52 Week High $123.18
52 Week Low $73.47
Volume 5,725,143
Shares Issued 2,474.63m
Market Cap $275,624m
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 10
Neutral 10
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 08-May-2026

Time Volume / Share Price
16:00 1,285,554 @ $111.38
16:00 457 @ $111.36
16:00 200 @ $111.36
16:00 1,440 @ $111.37
16:00 100 @ $111.38

Top of Page